Lamotrigine Dosing and Monitoring

Initial Dosing Strategy

The standard titration schedule for lamotrigine is critical to minimize the risk of serious rash, and the target dose is typically 200 mg/day for bipolar disorder and 100-500 mg/day for epilepsy, with monitoring for known or suspected malabsorption, poor treatment response, or significant drug interactions 1

Monitoring of lamotrigine plasma levels is recommended in cases of known or suspected malabsorption, poor treatment response, or significant drug interactions, with a putative therapeutic range of 1-4 mg/L 1

Strict adherence to the slow titration schedule is the primary strategy to minimize the risk of serious rash, and patients should be educated to report any rash immediately, with never exceeding recommended dose escalation rates 1

The recommended starting dose of lamotrigine is 25 mg once daily for the first two weeks, followed by gradual titration according to the specific condition being treated 2, 3
For patients with epilepsy who have been off lamotrigine for less than 5 days and have no history of rash or intolerance, a single oral loading dose of 6.5 mg/kg can be considered 2, 3
Restarting at the full dose after a period of discontinuation rather than re-titrating from the beginning is not recommended, and instead, re-titration from the beginning should be considered 2, 3

When coadministered with enzyme-inducing antiepileptic drugs such as phenytoin, carbamazepine, or phenobarbital, higher doses and more rapid titration of lamotrigine may be required, but must still follow safety protocols, and therapeutic drug monitoring is recommended, according to Clinical Infectious Diseases 4

The American Academy of Neurology recommends therapeutic drug monitoring when significant drug interactions are present, such as with enzyme-inducing antiepileptic drugs, to ensure safe and effective use of lamotrigine 4